Recruiting

TIS

Sponsor:

Northeastern University

Code:

NCT07593859

Conditions

Healthy Adult Participants

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

transcranial Temporal Interference Stimulation

Study Details

Brief summary:

Transcranial temporal interference stimulation (TIS) is an emerging novel tool for non-invasive transcranial brain stimulation that holds the potential for focal and steerable neuromodulation, and the possibility to stimulate focally at depth. TIS involves combining two high frequency waveforms to create a waveform with a "beat" frequency that is physiological relevant for neuromodulation. Successful applications to deep brain targets as well as steerability of the stimulation focus have been demonstrated in mice. Numerous recent investigations in humans have shown great clinical potential for this technology, however several questions about the basic mechanism of TIS action remain. The investigators will apply TIS to the motor cortex of humans and use established transcranial magnetic stimulation techniques to assess cortical excitability in relation to the phase of the TIS waveform. Using TMS, the investigators will i) validate that effects of TIS are due to the "beat" frequency and not the high frequency carrier signal, ii) evaluate the effect of the TIS carrier frequency, and iii) evaluate that whether changes in corticospinal excitability outlast the period of stimulation. Knowledge gained from this experiment will provide a basis for the future use of TIS for clinical applications, including informing parameter optimization.

Conditions

Healthy Adult Participants

Study ID

NCT07593859

Start date

Feb 1, 2026

Status verified date

May, 2026

Completion date

Oct 1, 2029

Anticipated

Primary completion date

Oct 1, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Free of neurological or orthopedic conditions that may impact the ability to participate.
  • Right-hand dominant (self-reported)
  • Aged 18-65 years

Exclusion Criteria:

  • Ferromagnetic metal implants in the brain/skull or elsewhere (dental implants excluded).
  • Any implanted electronic device (e.g. cardiac pacemaker, cochlear implant, deep brain stimulator, medication infusion pump; vagal nerve stimulator)
  • Diseased or damaged skin on face or scalp
  • History of migraines, fainting, seizures/epilepsy, or psychiatric illness
  • Neurological disorder or intracranial lesion
  • Frequent or severe headaches
  • Prior adverse reaction to transcranial magnetic stimulation
  • Currently pregnant
  • Suspected or diagnosed heart problems (e.g. arrhythmia, cardiac disturbances).
  • Insulin-dependent diabetes
  • Suspected or diagnosed epilepsy or a familial history of epilepsy
  • Use of alcohol or recreational drugs in the prior 12 hours
  • Use of prescription and over the counter medications will be grounds for exclusion except for: contraceptive (birth control) drugs (e.g. those containing ethinyl estradiol and/or norethindrone), and seasonal allergy medications (e.g. cetirizine (Zyrtec), fexofenadine (Allegra), and loratadine (Claritin)).

Study Design

Enrollment

30 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

experimental: 990-1010 Hz fb

990-1010 Hz fb

experimental: 1990-2010 Hz fb

1990-2010 Hz fb

experimental: 1000-1000 Hz fb

1000-1000 Hz fb

experimental: 2000-2000 Hz fb

2000-2000 Hz fb

experimental: 20 Hz

20 Hz

sham comparator: sham

sham

Interventions

transcranial Temporal Interference Stimulation

We will apply temporal interference stimulation (tTIS) for 20 minutes over the motor cortex concurrent with single-pulse transcranial magnetic stimulation (TMS) (also over the motor cortex). Motor evoked potentials will be recorded using electromyography (EMG).

Primary outcome measure

  • Online phase-dependent modulation of corticospinal excitability using the relevance value (R.V.) [ Time Frame: Periprocedural ]

Central Contacts and Locations

Central contacts

Locations

Northeastern University

Recruiting

Boston, Massachusetts, United States, 02115-5724

Contacts

Principal Investigator:

Mathew Yarossi, PhD

More Information

Sponsor

Northeastern University

Last update posted

May 18, 2026

Last verified

May, 2026

Keywords

  • transcranial temporal interference stimulation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Northeastern University on 2026-05-18.